Medina-Macías ML, Béjar-Ramírez YL, Lordméndez-Jácome D

Language: Spanish
References: 9
Page: 23-30
PDF size: 120.91 Kb.

ABSTRACT

The therapeutic aphaeresis has been tried for many situations in which a pathogenic antibody or an antigen complex antibody; in the case of Therapeutic Plasma Exchange (TPE), or abnormal cellular elements in the case of cytapheresis. Most of the treatment schemes they consist of daily spare parts of great volumes and by long periods. This intensity of spare parts is not necessary for the effective removal of pathological substances. The efficiency of the TPE not always is predictable although the removal of the injurious component is effective. The effects of the therapeutic cytapheresis are a little more predictable, although they tend to be of short duration unless a simultaneous treatment is provided to them.

REFERENCES

1. Isbister JP. Therapeutic Apheresis. Indian J Pediatr 2001; 68 (1): 61-7.

2. Gorlin JB. Therapeutic plasma exchange and cytapheresis in pediatric patients. Transfusion Science 1999; 21: 21-39.

3. Castellá CM. Recambio plasmático terapéutico: Sangre 1999; 44 (1): 76-9.

4. Smith JW, Weinstein R, Hillyer KL. Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis: Transfusion 2003; 43: 820-2.

5. Reimann PM, Mason PD. Review articles. Plasmapheresis: technique and complications. Intensive Care Med 1990; 16: 3-10.

6. Hester J. Therapeutic cell depletion. In: McLeod BC, Price TH, Weinstein R, editors, Apheresis: Principles and Practice, 2nd Edition Bethesda, MD, 2003: 283-94.

7. McLeod B. Introduction to the third special issue: Clinical applications of therapeutic apheresis. J Clin Apheresis 2000; 15: 1-5.

8. Everson D, Perry E, Kloster B, Hurley R, Stroncek D. Therapeutic apheresis for babesiosis. J Clin Apheresis 1998; 13: 32-6.

9. Kim H. Therapeutic pediatric apheresis. J Clin Apheresis 2000; 15: 129-57.